JV

Joanne L. Viney

PO Pandion Operations: 11 patents #1 of 17Top 6%
IM Immunex: 4 patents #64 of 178Top 40%
AM Amgen: 2 patents #1,289 of 2,867Top 45%
📍 Belmont, MA: #114 of 1,163 inventorsTop 10%
🗺 Massachusetts: #5,256 of 88,656 inventorsTop 6%
Overall (All Time): #202,967 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
RE50550 IL-2 muteins and uses thereof Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2025-08-26
11981715 Tissue targeted immunotolerance with a CD39 effector Daniel RIOS, Purvi Mande, Nathan Higginson-Scott, Kevin Lewis Otipoby, Susmita Borthakur +2 more 2024-05-14
11965008 IL-2 muteins and uses thereof Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2024-04-23
11945852 IL-2 muteins and uses thereof Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2024-04-02
11779632 IL-2 muteins and uses thereof Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2023-10-10
11739146 MAdCAM targeted immunotolerance Nathan Higginson-Scott, Kevin Lewis Otipoby, Jyothsna Visweswaraiah, Salvatore Alioto, Lindsay J. Edwards +6 more 2023-08-29
11466068 Targeted immunotolerance Nathan Higginson-Scott 2022-10-11
11459370 BTNL3 proteins, nucleic acids and antibodies and uses thereof Heather A. Arnett, Sabine S. Escobar, Ryan Swanson 2022-10-04
11091526 IL-2 muteins and uses thereof Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2021-08-17
11091527 IL-2 muteins and uses thereof Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2021-08-17
10961310 Targeted immunotolerance Nathan Higginson-Scott, Micah Benson, Alan Crane 2021-03-30
10946068 IL-2 muteins and uses thereof Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2021-03-16
10676516 Targeted immunotolerance Nathan Higginson-Scott 2020-06-09
10357561 BTNL9 proteins, nucleic acids, and antibodies and uses thereof Heather A. Arnett, Sabine S. Escobar, Ryan Swanson 2019-07-23
10174091 IL-2 muteins Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2019-01-08
10174092 IL-2 muteins Nathan Higginson-Scott, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby 2019-01-08
8674078 Methods of using BTL-II proteins Peter Robert Baum, Sabine S. Escobar 2014-03-18
8609655 Calcimimetic compound for use in the treatment of epithelial injury John P. Geibel, Steven C. Hebert, David Martin, Gordon Yiu Kon Ng, William Gleason Richards 2013-12-17
8173603 Methods of using BTL-II proteins Peter Robert Baum, Sabine S. Escobar 2012-05-08
7709618 BTL-II nucleic acids Peter Robert Baum, Sabine S. Escobar 2010-05-04
7244822 BTL-II proteins Peter Robert Baum, Sabine S. Escobar 2007-07-17